{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:39:50Z","timestamp":1771558790134,"version":"3.50.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s11908-016-0515-z","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T09:02:22Z","timestamp":1454403742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hepatitis E in Transplantation"],"prefix":"10.1007","volume":"18","author":[{"given":"Olivier","family":"Marion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Abravanel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,2]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","volume":"379","author":"N Kamar","year":"2012","unstructured":"Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet. 2012;379:2477\u201388. This is a comprehensive review summarizing current knowledge about hepatitis E virus.","journal-title":"Lancet"},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.coviro.2014.12.006","volume":"10","author":"N Pavio","year":"2015","unstructured":"Pavio N, Meng XJ, Doceul V. Zoonotic origin of hepatitis E. Curr Opin Virol. 2015;10:34\u201341. This is a comprehensive review summarizing the mode of transmission of hepatitis E virus.","journal-title":"Curr Opin Virol"},{"issue":"18","key":"515_CR3","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1128\/JVI.00593-10","volume":"84","author":"SU Emerson","year":"2010","unstructured":"Emerson SU, Nguyen HT, Torian U, Burke D, Engle R, Purcell RH. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J Virol. 2010;84(18):9059\u201369.","journal-title":"J Virol"},{"issue":"11","key":"515_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2169\/internalmedicine.42.1065","volume":"42","author":"H Okamoto","year":"2003","unstructured":"Okamoto H, Takahashi M, Nishizawa T. Features of hepatitis E virus infection in Japan. Intern Med. 2003;42(11):1065\u201371.","journal-title":"Intern Med"},{"issue":"8","key":"515_CR5","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1128\/JVI.02762-12","volume":"87","author":"DB Smith","year":"2013","unstructured":"Smith DB, Purdy MA, Simmonds P. Genetic variability and the classification of hepatitis e virus. J Virol. 2013;87(8):4161\u20139.","journal-title":"J Virol"},{"issue":"7","key":"515_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3201\/eid2107.141909","volume":"21","author":"S Lhomme","year":"2015","unstructured":"Lhomme S, Top S, Bertagnoli S, Dubois M, Guerin JL, Izopet J. Wildlife reservoir for hepatitis E virus, Southwestern France. Emerg Infect Dis. 2015;21(7):1224\u20136.","journal-title":"Emerg Infect Dis"},{"issue":"19","key":"515_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2807\/1560-7917.ES2015.20.19.21127","volume":"20","author":"JM Mansuy","year":"2015","unstructured":"Mansuy JM, Saune K, Rech H, Abravanel F, Mengelle C, LH S, et al. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011. Euro Surveill. 2015;20(19):27\u201334.","journal-title":"Euro Surveill"},{"issue":"3","key":"515_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12560-015-9196-2","volume":"7","author":"N Cook","year":"2015","unstructured":"Cook N, van der Poel WH. Survival and elimination of hepatitis E virus: a review. Food Environ Virol. 2015;7(3):189\u201394.","journal-title":"Food Environ Virol"},{"issue":"4","key":"515_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jcv.2013.10.003","volume":"58","author":"F Abravanel","year":"2013","unstructured":"Abravanel F, Chapuy-Regaud S, Lhomme S, Miedouge M, Peron JM, Alric L, et al. Performance of anti-HEV assays for diagnosis acute hepatitis E in immunocompromised patients. J Clin Virol. 2013;58(4):624\u20138.","journal-title":"J Clin Virol"},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jcv.2015.07.302","volume":"70","author":"F Abravanel","year":"2015","unstructured":"Abravanel F, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L, Rostaing L, et al. Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients. J Clin Virol. 2015;70:101\u20134.","journal-title":"J Clin Virol"},{"issue":"5","key":"515_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/jmv.21656","volume":"82","author":"R Bendall","year":"2010","unstructured":"Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82(5):799\u2013805.","journal-title":"J Med Virol"},{"issue":"12","key":"515_CR12","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3201\/eid1712.110371","volume":"17","author":"JM Mansuy","year":"2011","unstructured":"Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, et al. Hepatitis E virus antibody in blood donors, France. Emerg Infect Dis. 2011;17(12):2309\u201312.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"515_CR13","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1128\/JCM.02578-10","volume":"49","author":"SA Baylis","year":"2011","unstructured":"Baylis SA, Hanschmann KM, Blumel J, Nubling CM. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol. 2011;49(4):1234\u20139.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"515_CR14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1128\/JCM.05942-11","volume":"50","author":"F Abravanel","year":"2012","unstructured":"Abravanel F, Sandres-Saune K, Lhomme S, Dubois M, Mansuy JM, Izopet J. Genotype 3 diversity and quantification of hepatitis E virus RNA. J Clin Microbiol. 2012;50(3):897\u2013902.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"515_CR15","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/ajt.12253","volume":"13","author":"N Kamar","year":"2013","unstructured":"Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J. How should hepatitis E virus infection be defined in organ-transplant recipients? Am J Transplant. 2013;13(7):1935\u20136.","journal-title":"Am J Transplant"},{"key":"515_CR16","doi-asserted-by":"crossref","unstructured":"Kamar N, Lhomme S, Abravanel F, Cointault O, Esposito L, Cardeau-Desangles I et al. An early viral response predicts the virological response to ribavirin in hepatitis E virus organ transplant patients. Transplantation. 2015","DOI":"10.1097\/TP.0000000000000850"},{"issue":"1","key":"515_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciu742","volume":"60","author":"F Abravanel","year":"2015","unstructured":"Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Clin Infect Dis. 2015;60(1):96\u20139.","journal-title":"Clin Infect Dis"},{"issue":"9956","key":"515_CR18","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","volume":"384","author":"PE Hewitt","year":"2014","unstructured":"Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384(9956):1766\u201373. In this original paper, the authors elegantly demonstrate the risk of transmission of hepatitis E virus by blood tranfusion.","journal-title":"Lancet"},{"issue":"11","key":"515_CR19","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3201\/eid2011.140516","volume":"20","author":"P Gallian","year":"2014","unstructured":"Gallian P, Lhomme S, Piquet Y, Saune K, Abravanel F, Assal A, et al. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis. 2014;20(11):1914\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"515_CR20","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1097\/TP.0b013e318296c9f7","volume":"96","author":"A Coilly","year":"2013","unstructured":"Coilly A, Haim-Boukobza S, Roche B, Antonini TM, Pause A, Mokhtari C, et al. Posttransplantation hepatitis e: transfusion-transmitted hepatitis rising from the ashes. Transplantation. 2013;96(2):e4\u20136.","journal-title":"Transplantation"},{"issue":"2","key":"515_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jhep.2011.06.021","volume":"56","author":"B Schlosser","year":"2012","unstructured":"Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Kruger DH, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol. 2012;56(2):500\u20132.","journal-title":"J Hepatol"},{"issue":"12","key":"515_CR22","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/infdis\/jiu032","volume":"209","author":"F Abravanel","year":"2014","unstructured":"Abravanel F, Lhomme S, Chapuy-Regaud S, Mansuy JM, Muscari F, Sallusto F, et al. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis. 2014;209(12):1900\u20136.","journal-title":"J Infect Dis"},{"issue":"5","key":"515_CR23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jmv.21140","volume":"80","author":"W Huang","year":"2008","unstructured":"Huang W, Zhang H, Harrison TJ, Lang S, Huang G, Wang Y. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques. J Med Virol. 2008;80(5):824\u201332.","journal-title":"J Med Virol"},{"issue":"11","key":"515_CR24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","volume":"8","author":"HR Dalton","year":"2008","unstructured":"Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698\u2013709.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"515_CR25","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","volume":"140","author":"N Kamar","year":"2011","unstructured":"Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140(5):1481\u20139.","journal-title":"Gastroenterology"},{"issue":"10","key":"515_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03504.x","volume":"26","author":"HR Dalton","year":"2007","unstructured":"Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther. 2007;26(10):1429\u201335.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"515_CR27","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","volume":"141","author":"TJ Davern","year":"2011","unstructured":"Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011;141(5):1665\u201372.","journal-title":"Gastroenterology"},{"issue":"1","key":"515_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/CMR.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):116\u201338.","journal-title":"Clin Microbiol Rev"},{"issue":"9569","key":"515_CR29","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(07)60595-9","volume":"369","author":"HR Dalton","year":"2007","unstructured":"Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet. 2007;369(9569):1260.","journal-title":"Lancet"},{"issue":"5","key":"515_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2893.2007.00858.x","volume":"14","author":"JM Peron","year":"2007","unstructured":"Peron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14(5):298\u2013303.","journal-title":"J Viral Hepat"},{"issue":"8","key":"515_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811\u20137.","journal-title":"N Engl J Med"},{"issue":"10","key":"515_CR32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJMc0903778","volume":"361","author":"HR Dalton","year":"2009","unstructured":"Dalton HR, Bendall R, Keane F, Tedder R, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361(10):1025\u201327.","journal-title":"N Engl J Med"},{"issue":"5","key":"515_CR33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/gut.2008.165571","volume":"58","author":"P le Coutre","year":"2009","unstructured":"le Coutre P, Meisel H, Hofmann J, Rocken C, Vuong GL, Neuburger S, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut. 2009;58(5):699\u2013702.","journal-title":"Gut"},{"key":"515_CR34","doi-asserted-by":"crossref","unstructured":"Meisner S, Polywka S, Memmler M, Nashan B, Lohse AW, Sterneck M et al. Definition of chronic hepatitis E after liver transplant conforms to convention. Am J Transplant. 2015","DOI":"10.1111\/ajt.13428"},{"issue":"3","key":"515_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","volume":"89","author":"N Kamar","year":"2010","unstructured":"Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssiere L, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation. 2010;89(3):353\u201360.","journal-title":"Transplantation"},{"key":"515_CR36","first-page":"CD003961","volume":"4","author":"A Webster","year":"2005","unstructured":"Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev. 2005;4:CD003961.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"515_CR37","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1053\/j.gastro.2014.02.036","volume":"146","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhou X, Debing Y, Chen K, Van der Laan LJ, Neyts J, et al. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology. 2014;146(7):1775\u201383.","journal-title":"Gastroenterology"},{"key":"515_CR38","doi-asserted-by":"crossref","unstructured":"Zhou X, Wang Y, Metselaar HJ, Janssen HL, Peppelenbosch MP, Pan Q. Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway. J Hepatol. 2014","DOI":"10.1016\/j.jhep.2014.05.026"},{"issue":"3","key":"515_CR39","first-page":"695","volume":"55","author":"PV Suneetha","year":"2012","unstructured":"Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert AA, et al. HEV-specific T-cell responses are associated with control of HEV infection. Hepatology (Baltimore. MD. 2012;55(3):695\u2013708.","journal-title":"MD"},{"issue":"18","key":"515_CR40","doi-asserted-by":"publisher","first-page":"100006","DOI":"10.1128\/JVI.01003-12","volume":"86","author":"S Lhomme","year":"2012","unstructured":"Lhomme S, Abravanel F, Dubois M, Sandres Saune K, Rostaing L, Kamar N, et al. HEV quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol. 2012;86(18):100006\u201314.","journal-title":"J Virol"},{"issue":"2","key":"515_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/infdis\/jit438","volume":"209","author":"S Lhomme","year":"2014","unstructured":"Lhomme S, Garrouste C, Kamar N, Saune K, Abravanel F, Mansuy JM, et al. Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients. J Infect Dis. 2014;209(2):300\u20133.","journal-title":"J Infect Dis"},{"issue":"2","key":"515_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jcv.2012.02.015","volume":"54","author":"F Abravanel","year":"2012","unstructured":"Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol. 2012;54(2):152\u20135.","journal-title":"J Clin Virol"},{"issue":"1","key":"515_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1399-3062.2011.00702.x","volume":"14","author":"C Knoenecke","year":"2012","unstructured":"Knoenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in low-endemic country. Transpl Infect Dis. 2012;14(1):103\u20136.","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"515_CR44","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2013-03-492363","volume":"122","author":"J Versluis","year":"2013","unstructured":"Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood. 2013;122(6):1079\u201386.","journal-title":"Blood"},{"issue":"1","key":"515_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/bmt.2013.148","volume":"49","author":"C Koenecke","year":"2014","unstructured":"Koenecke C, Pischke S, Beutel G, Ritter U, Ganser A, Wedemeyer H, et al. Hepatitis E virus infection in a hematopoietic stem cell donor. Bone Marrow Transplant. 2014;49(1):159\u201360.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"515_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jcv.2010.06.016","volume":"49","author":"S Tavitian","year":"2010","unstructured":"Tavitian S, Peron JM, Huynh A, Mansuy JM, Ysebaert L, Huguet F, et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol. 2010;49(2):141\u20134.","journal-title":"J Clin Virol"},{"issue":"5","key":"515_CR47","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jpeds.2012.01.028","volume":"160","author":"U Halac","year":"2012","unstructured":"Halac U, Beland K, Lapierre P, Patey N, Ward P, Brassard J, et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr. 2012;160(5):871\u20134.","journal-title":"J Pediatr"},{"issue":"2","key":"515_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3201\/eid1702.100856","volume":"17","author":"N Kamar","year":"2011","unstructured":"Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis. 2011;17(2):173\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"515_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","volume":"82","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, et al. Guillain-Barre syndrome associated with preceding hepatitis E virus infection. Neurology. 2014;82(6):491\u20137. This is case-controlled study showing an association between hepatitis E virus and Guillain-Barr\u00e9 syndrome.","journal-title":"Neurology"},{"issue":"6","key":"515_CR50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/WNL.0000000000000112","volume":"82","author":"JJ van Eijk","year":"2014","unstructured":"van Eijk JJ, Madden RG, van der Eijk AA, Hunter JG, Reimerink JH, Bendall RP, et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology. 2014;82(6):498\u2013503. This is case-controlled study showing an association between hepatitis E virus and neuralgic amyotrophy.","journal-title":"Neurology"},{"issue":"5","key":"515_CR51","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/j.1600-6143.2010.03068.x","volume":"10","author":"N Kamar","year":"2010","unstructured":"Kamar N, Izopet J, Cintas P, Garrouste C, Uro-Coste E, Cointault O, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant. 2010;10(5):1321\u20134.","journal-title":"Am J Transplant"},{"issue":"1","key":"515_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/j.ajkd.2004.09.006","volume":"45","author":"N Kamar","year":"2005","unstructured":"Kamar N, Mansuy JM, Esposito L, Legrand-Abravanel F, Peron JM, Durand D, et al. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am J Kidney Dis. 2005;45(1):193\u20136.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"515_CR53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e318245f14c","volume":"93","author":"N Kamar","year":"2012","unstructured":"Kamar N, Weclawiack H, Guilbeaud-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, et al. Hepatitis E virus and the kidney in solid-organ-transplant patients. Transplantation. 2012;93(6):617\u201323.","journal-title":"Transplantation"},{"issue":"6","key":"515_CR54","doi-asserted-by":"publisher","first-page":"E211","DOI":"10.1111\/tid.12143","volume":"15","author":"B Taton","year":"2013","unstructured":"Taton B, Moreau K, Lepreux S, Bachelet T, Trimoulet P, De Ledinghen V, et al. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation. Transpl Infect Dis. 2013;15(6):E211\u20135.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"515_CR55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/tid.12353","volume":"17","author":"A Del Bello","year":"2015","unstructured":"Del Bello A, Guilbeau-Frugier C, Josse AG, Rostaing L, Izopet J, Kamar N. Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin. Transpl Infect Dis. 2015;17(2):279\u201383.","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"515_CR56","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1473-3099(14)70823-0","volume":"14","author":"S Pischke","year":"2014","unstructured":"Pischke S, Behrendt P, Manns MP, Wedemeyer H. HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E. Lancet Infect Dis. 2014;14(8):678\u20139.","journal-title":"Lancet Infect Dis"},{"key":"515_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jcv.2015.03.020","volume":"67","author":"S Pischke","year":"2015","unstructured":"Pischke S, Polywka S, Haag F, Iking-Konert C, Sterneck M, Lutgehetmann M, et al. Association of hepatitis E virus and essential cryoglobulinemia? J Clin Virol. 2015;67:23\u20134.","journal-title":"J Clin Virol"},{"issue":"5","key":"515_CR58","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1086\/650488","volume":"50","author":"N Kamar","year":"2010","unstructured":"Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010;50(5):e30\u20133.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"515_CR59","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1093\/ndt\/gfq282","volume":"25","author":"N Kamar","year":"2010","unstructured":"Kamar N, Abravanel F, Garrouste C, Cardeau-Desangles I, Mansuy JM, Weclawiak H, et al. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant. 2010;25(8):2792\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"515_CR60","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.22014","volume":"16","author":"EB Haagsma","year":"2010","unstructured":"Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl. 2010;16(4):474\u20137.","journal-title":"Liver Transpl"},{"issue":"10","key":"515_CR61","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","volume":"59","author":"L Rostaing","year":"1995","unstructured":"Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation. 1995;59(10):1426\u201331.","journal-title":"Transplantation"},{"issue":"2","key":"515_CR62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-153-2-201007200-00257","volume":"153","author":"V Mallet","year":"2010","unstructured":"Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tesse S, Thervet E, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med. 2010;153(2):85\u20139.","journal-title":"Ann Intern Med"},{"issue":"5","key":"515_CR63","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","volume":"139","author":"N Kamar","year":"2010","unstructured":"Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenterology. 2010;139(5):1612\u20138.","journal-title":"Gastroenterology"},{"issue":"5","key":"515_CR64","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/liv.12114","volume":"33","author":"S Pischke","year":"2013","unstructured":"Pischke S, Hardkte S, Bode U, Birkner S, Chatzikyrkou C, Kauffmann W, et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int. 2013;33(5):722\u20136.","journal-title":"Liver Int"},{"issue":"12","key":"515_CR65","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","volume":"370","author":"N Kamar","year":"2014","unstructured":"Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370(12):1111\u201320. It is a retrospective multicenter study that showed that ribavirin monotherapy is highly efficient for treating hepatitis E virus infection.","journal-title":"N Engl J Med"},{"key":"515_CR66","volume-title":"Manns M et al","author":"Y Debing","year":"2014","unstructured":"Debing Y, Gisa A, Dallmeier K, Pischke S, Bremer B. Manns M et al. Gastroenterology: A Mutation in the Hepatitis E Virus RNA Polymerase Promotes its Replication and Associates with Ribavirin Treatment Failure in Organ Transplant Recipients; 2014."},{"issue":"1","key":"515_CR67","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/AAC.01795-13","volume":"58","author":"Y Debing","year":"2014","unstructured":"Debing Y, Emerson SU, Wang Y, Pan Q, Balzarini J, Dallmeier K, et al. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob Agents Chemother. 2014;58(1):267\u201373.","journal-title":"Antimicrob Agents Chemother"},{"issue":"25","key":"515_CR68","first-page":"2447","volume":"370","author":"N Kamar","year":"2014","unstructured":"Kamar N, Mallet V, Izopet J. Ribavirin for chronic hepatitis E virus infection. N Engl J Med. 2014;370(25):2447\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"515_CR69","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1600-6143.2011.03838.x","volume":"12","author":"N Kamar","year":"2012","unstructured":"Kamar N, Izopet J, Rostaing L. No reactivation of hepatitis E virus after kidney retransplantation. Am J Transplant. 2012;12(2):507\u20138.","journal-title":"Am J Transplant"},{"issue":"9744","key":"515_CR70","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","volume":"376","author":"FC Zhu","year":"2010","unstructured":"Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376(9744):895\u2013902.","journal-title":"Lancet"},{"issue":"10","key":"515_CR71","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1406011","volume":"372","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372(10):914\u201322. This paper confirms the long-term efficacy of the Chinese hepatitis E virus vaccine.","journal-title":"N Engl J Med"},{"issue":"1","key":"515_CR72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3201\/eid1701.100527","volume":"17","author":"F Legrand-Abravanel","year":"2011","unstructured":"Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis. 2011;17(1):30\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"515_CR73","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1086\/655899","volume":"202","author":"F Legrand-Abravanel","year":"2010","unstructured":"Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis. 2010;202(6):835\u201344.","journal-title":"J Infect Dis"},{"issue":"6","key":"515_CR74","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10096-013-2042-2","volume":"33","author":"C Buffaz","year":"2014","unstructured":"Buffaz C, Scholtes C, Dron AG, Chevallier-Queyron P, Ritter J, Andre P, et al. Hepatitis E in liver transplant recipients in the Rhone-Alpes region in France. Eur J Clin Microbiol Infect Dis. 2014;33(6):1037\u201343.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"515_CR75","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/lt.21925","volume":"16","author":"M Buti","year":"2010","unstructured":"Buti M, Cabrera C, Jardi R, Castells L, Esteban R. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl. 2010;16(1):106\u20137.","journal-title":"Liver Transpl"},{"issue":"10","key":"515_CR76","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/lt.21819","volume":"15","author":"EB Haagsma","year":"2009","unstructured":"Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009;15(10):1225\u20138.","journal-title":"Liver Transpl"},{"issue":"1","key":"515_CR77","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12879-015-1103-9","volume":"15","author":"L Koning","year":"2015","unstructured":"Koning L, Charlton MR, Pas SD, Heimbach JK, Osterhaus AD, Watt KD, et al. Prevalence and clinical consequences of hepatitis E in patients who underwent liver transplantation for chronic hepatitis C in the United States. BMC Infect Dis. 2015;15(1):371.","journal-title":"BMC Infect Dis"},{"key":"515_CR78","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jcv.2015.04.022","volume":"69","author":"N Laverdure","year":"2015","unstructured":"Laverdure N, Scholtes-Brunel C, Rivet C, Heissat S, Restier L, Bacchetta J, et al. Paediatric liver transplanted patients and prevalence of hepatitis E virus. J Clin Virol. 2015;69:22\u20136.","journal-title":"J Clin Virol"},{"issue":"3","key":"515_CR79","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/jmv.23469","volume":"85","author":"V Moal","year":"2012","unstructured":"Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, et al. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol. 2012;85(3):462\u201371.","journal-title":"J Med Virol"},{"issue":"5","key":"515_CR80","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1128\/JCM.03624-14","volume":"53","author":"V Moal","year":"2015","unstructured":"Moal V, Legris T, Motte A, Vacher-Coponat H, Fages L, Jourde-Chiche N, et al. Systematic serological testing for hepatitis E virus in kidney transplant recipients. J Clin Microbiol. 2015;53(5):1523\u201330.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"515_CR81","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.transproceed.2015.04.092","volume":"47","author":"J Magnusson","year":"2015","unstructured":"Magnusson J, Norder H, Riise GC, Andersson LM, Brittain-Long R, Westin J. Incidence of hepatitis E antibodies in Swedish lung transplant recipients. Transplant Proc. 2015;47(6):1972\u20136.","journal-title":"Transplant Proc"},{"issue":"4","key":"515_CR82","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1111\/jvh.12027","volume":"20","author":"A Naik","year":"2013","unstructured":"Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat. 2013;20(4):e138\u201340.","journal-title":"J Viral Hepat"},{"issue":"5","key":"515_CR83","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3201\/eid1805.111712","volume":"18","author":"SD Pas","year":"2012","unstructured":"Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT, Weimar W, et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis. 2012;18(5):869\u201372.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"515_CR84","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/lt.21958","volume":"16","author":"S Pischke","year":"2010","unstructured":"Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl. 2010;16(1):74\u201382.","journal-title":"Liver Transpl"},{"issue":"11","key":"515_CR85","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1111\/j.1600-6143.2012.04200.x","volume":"12","author":"S Pischke","year":"2012","unstructured":"Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant. 2012;12(11):3128\u201333.","journal-title":"Am J Transplant"},{"issue":"2","key":"515_CR86","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/tid.12183","volume":"16","author":"S Pischke","year":"2014","unstructured":"Pischke S, Greer M, Hardtke S, Bremer B, Gisa A, Lehmann P, et al. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transpl Infect Dis. 2014;16(2):333\u20139.","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"515_CR87","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.healun.2012.11.027","volume":"32","author":"A Riezebos-Brilman","year":"2013","unstructured":"Riezebos-Brilman A, Puchhammer-St\u00f6ckl E, Van der Weide H, Haagsma EB, Jaksch P, Bejvl I, et al. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant. 2013;32(3):341\u20136.","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"515_CR88","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/jvh.12233","volume":"21","author":"KE Sherman","year":"2014","unstructured":"Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT, Investigators H-T. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. J Viral Hepat. 2014;21(8):e74\u20137.","journal-title":"J Viral Hepat"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-016-0515-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-016-0515-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-016-0515-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-016-0515-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T08:37:58Z","timestamp":1748767078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-016-0515-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,2]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1007\/s11908-016-0515-z","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,2]]},"assertion":[{"value":"2 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Drs Marion, Abravanel, Lhomme, Izopet, and Kamar declare no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"8"}}